Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study

BACKGROUND/AIM: To evaluate the applicability of transarterial chemoembolization (TACE) treatment with doxorubicin drug-eluting beads (DEBs) in advanced hepatocellular carcinoma (HCC) patients with portal vein invasion (PVI). METHODS: This prospective study was approved by the institutional review b...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Su Jong, Lee, Yun Bin, Cho, Eun Ju, Lee, Jeong-Hoon, Kim, Hyo-Cheol, Chung, Jin Wook, Yoon, Jung-Hwan, Kim, Yoon Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Liver Cancer Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202235/
https://www.ncbi.nlm.nih.gov/pubmed/37384028
http://dx.doi.org/10.17998/jlc.2023.02.08

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202235/
https://www.ncbi.nlm.nih.gov/pubmed/37384028
http://dx.doi.org/10.17998/jlc.2023.02.08

Ejemplares similares